On 13 February, 2014, Shenzhen Development and Reform Commission officially announced that the “2014 Shenzhen Major Project Plan” has been approved and released the names that have been included in the plan. This is the fourth successive year that "Shenzhen Kangzhe New Drug Manufactive Site Construction Project” is included in the plan since 2011.
Shenzhen Kangzhe New Drug Manufactive Site is located at Jinsha District, Pingshan new area, Shenzhen, which is used for the production of Tyroserleutide, an in-house researched and developed National Class 1.1 new drug, and other drugs. The project will bring great economic and social benefits after it completion, not only promote the development of Chinese healthcare industry, but also contribute to lift the international competitiveness of the industry.